These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15570868)

  • 1. [Treatment of nonalcoholic steatohepatitis (NASH)].
    Nakashima T; Sumida Y; Mitsuyoshi H; Okanoue T
    Nihon Shokakibyo Gakkai Zasshi; 2004 Nov; 101(11):1204-8. PubMed ID: 15570868
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of nonalcoholic steatohepatitis: an analytic review.
    Agrawal S; Bonkovsky HL
    J Clin Gastroenterol; 2002 Sep; 35(3):253-61. PubMed ID: 12192203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): The other face of the coin of histology.
    Ahmed MH
    Med Hypotheses; 2006; 66(3):679-80. PubMed ID: 16289367
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic strategies for hepatitis C].
    Tsubota A; Kumada H
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):441-7. PubMed ID: 15359839
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of glycyrrhizin for recurrence of hepatitis B after liver transplantation.
    Matsunami H; Lynch SV; Balderson GA; Strong RW
    Am J Gastroenterol; 1993 Jan; 88(1):152-3. PubMed ID: 8420262
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical aspects of type-C cirrhosis of liver--diagnosis, clinical course, treatment and prognosis].
    Yamada G
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):590-5. PubMed ID: 15359866
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment.
    Ersöz G; Günşar F; Karasu Z; Akay S; Batur Y; Akarca US
    Turk J Gastroenterol; 2005 Sep; 16(3):124-8. PubMed ID: 16245220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fatty liver and its clinical management in obese adolescents].
    González Jiménez E; Schmidt Río-Valle J; Álvarez Ferre J
    Endocrinol Nutr; 2011 Jan; 58(1):32-7. PubMed ID: 21216209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
    Park SH
    Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic steatohepatitis and the metabolic syndrome.
    Jiang J; Torok N
    Metab Syndr Relat Disord; 2008 Mar; 6(1):1-7. PubMed ID: 18370830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of and therapy for nonalcoholic steatohepatitis].
    Onishi S; Saibara T
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1876-80. PubMed ID: 17037330
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-alcoholic steatohepatitis].
    Alvarez-Martínez H; Pérez-Campos E
    Rev Gastroenterol Mex; 2002; 67(2):118-25. PubMed ID: 12214335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy for nonalcoholic fatty liver disease.
    Moseley RH
    J Clin Gastroenterol; 2008 Apr; 42(4):332-5. PubMed ID: 18277910
    [No Abstract]   [Full Text] [Related]  

  • 15. [Alternative therapies for hepatitis C: UDCA and SNMC].
    Matsuzaki Y; Ikegami T; Saito Y
    Nihon Rinsho; 2011 May; 69 Suppl 4():256-61. PubMed ID: 22096928
    [No Abstract]   [Full Text] [Related]  

  • 16. [Alcoholic and non-alcoholic steatohepatitis].
    Dufour JF; Oneta CM
    Ther Umsch; 2004 Aug; 61(8):505-12. PubMed ID: 15457967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon therapy in hepatitis C virus (HCV) induced chronic hepatitis: clinical significance of pretreatment with glycyrhizine.
    Fujisawa K
    Trop Gastroenterol; 1991; 12(4):176-9. PubMed ID: 1726032
    [No Abstract]   [Full Text] [Related]  

  • 18. [Alternative measures for patients with chronic hepatitis C unresponsive to interferon therapy].
    Imazeki F
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):540-3. PubMed ID: 15359858
    [No Abstract]   [Full Text] [Related]  

  • 19. Nonalcoholic steatohepatitis.
    Sanyal A
    Indian J Gastroenterol; 2001 Mar; 20 Suppl 1():C64-70. PubMed ID: 11293184
    [No Abstract]   [Full Text] [Related]  

  • 20. [Nonalcoholic steatohepatitis--a "new" hepatic disease].
    Grønbaek H; Eivindson MV; Hamilton-Dutoit S; Vilstrup H
    Ugeskr Laeger; 2003 Mar; 165(11):1115-8. PubMed ID: 12677985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.